← Back
$MLYS All transactions

Mineralys Therapeutics, Inc.

A

$ Value

$0

Shares

6,200

Price

$0

Filed

Feb 20

Insider

Name

AKKARAJU SRINIVAS

Title

CIK

0001253170

Roles

Director 10% Owner

Transaction Details

Transaction Date

2026-02-19

Code

A

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

6,200

Footnotes

Restricted Stock Units (RSUs) are granted to the reporting person for no additional cash consideration, each of which represents a contingent right to receive one share of common stock upon vesting of these RSUs in one annual installment following the date of grant. | Of this amount, 588,235 shares are directly held by Samsara Opportunity Fund, L.P. (Samsara Opp LP). Samsara Opportunity Fund GP, LLC (Samsara Opp GP) is the general partner of Samsara Opp LP and may be deemed to beneficially own the securities held by Samsara Opp LP. Dr. Akkaraju has voting and investment power over the shares held by Samsara Opp LP and, accordingly, may be deemed to beneficially own the shares held by Samsara Opp LP. Also, of this amount, 5,282,783 shares are directly held by Samsara BioCapital L.P. (Samsara LP). Samsara BioCapital GP, LLC (Samsara LLC) is the general partner of Samsara LP and may be deemed to beneficially own the securities held by Samsara LP. Dr. Akkaraju has voting and investment power over the shares held by Samsara LP and, accordingly, may be deemed to beneficially own the shares held by Samsara LP. Dr. Akkaraju disclaims beneficial ownership in these securities except to the extent of his pecuniary interest therein. | The stock option vests in 12 substantially equal monthly installments following the date of grant.

Filing Info

Accession No.

0001933414-26-000040

Form Type

4

Issuer CIK

0001933414

AKKARAJU SRINIVAS's History

Date Ticker Type Value
2026-02-19 MLYS A $0
2026-02-19 MLYS A $0
2026-01-09 ALMS $10.0M
2025-12-22 KLRS A $15.0M
2025-12-18 KLRS $5.0M
2025-12-12 SRRK X $7.8M
2025-12-12 SRRK X $0
2025-12-05 ALMS $581K
2025-12-05 ALMS $701K
2025-12-05 ALMS $551K

Other Insiders at MLYS (90d)

Insider Bought Sold Last
RA CAPITAL MANAGEMENT, L.P. $8.8M 2026-03-30
AKKARAJU SRINIVAS 2026-02-19
SBLENDORIO GLENN 2026-02-19
Congleton Jon
Chief Executive Officer
$2.4M 2026-04-13
Rodman David Malcom
Chief Medical Officer
$1.9M 2026-04-17
Levy Adam Scott
CFO and Secretary
2026-02-19
DiRocco Derek 2026-02-19
Karydas Daphne $75K 2026-03-31
Slingsby Brian Taylor 2026-02-19
Gold Alexander M 2026-02-19